11 September 2020>: Clinical Research
A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China
Miao Yang 1ACDEG , Xiaoping Chen 2ABCF* , Yancheng Xu 1ADFG*DOI: 10.12659/MSM.926393
Med Sci Monit 2020; 26:e926393
Table 4 Comparison of ROC curves in severe COVID-19 patients.
Variables | Difference between areas | SE | 95%CI | P-value |
---|---|---|---|---|
CRP~CRP/LYM | 0.005 | 0.023 | −0.039 to 0.049 | 0.8254 |
CRP~LYM | 0.144 | 0.069 | 0.009 to 0.280 | 0.0372 |
CRP/LYM~LYM | 0.139 | 0.051 | 0.040 to 0.238 | 0.0061 |
CRP – C-reactive protein; LYM – lymphocytes; CRP/LYM – the ratio of C-reactive protein to lymphocytes; AUC – areas under the curve; 95% CI – 95% confidence interval; SE – standard error. |